In Brief

Blood from recovered patients being tested as COVID-19 treatment

Donated blood.
The coronavirus could cause shortages in the nation’s blood supply. (Image credit: Shutterstock)

Doctors in New York will soon test an experimental therapy for COVID-19 that uses blood from people who recover from the disease, according to news reports.

The therapy, known as convalescent plasma, takes advantage of the virus-fighting antibodies that are present in people's blood after they recover from the illness, according to NBC News

For the trial, researchers would collect plasma — the liquid portion of blood that does not include blood cells or platelets — from recovered COVID-19 patients. Researchers would then harvest antibodies against the new coronavirus from the plasma, and these antibodies would then be injected into people sick with COVID-19. The study researchers will then evaluate whether convalescent plasma improves disease outcomes.

"There have been tests that show when a person is injected with the antibodies, that then stimulates and promotes their immune system against that disease," Gov. Andrew Cuomo said at a news briefing Monday (March 23). 

The trial, which officials plan to start this week, would only treat people who are seriously ill with COVID-19, Cuomo said.

This type of therapy is more than 100 years old and was used during the 1918 flu pandemic, a time when antiviral drugs and most vaccines did not exist, according to NBC News.

Recruiting for plasma donors would likely start in New Rochelle, a suburb of New York City where many of the state's initial cases occurred, according to NBC.

Originally published on Live Science. 

OFFER: Save at least 53% with our latest magazine deal!

<a href="" data-link-merchant=""" target="_blank">OFFER: Save at least 53% with our latest magazine deal!

With impressive cutaway illustrations that show how things function, and mindblowing photography of the world’s most inspiring spectacles, <a href="" data-link-merchant=""" data-link-merchant=""">How It Works represents the pinnacle of engaging, factual fun for a mainstream audience keen to keep up with the latest tech and the most impressive phenomena on the planet and beyond. Written and presented in a style that makes even the most complex subjects interesting and easy to understand, <a href="" data-link-merchant=""" data-link-merchant=""" data-link-merchant=""">How It Works is enjoyed by readers of all ages.

Rachael Rettner

Rachael is a Live Science contributor, and was a former channel editor and senior writer for Live Science between 2010 and 2022. She has a master's degree in journalism from New York University's Science, Health and Environmental Reporting Program. She also holds a B.S. in molecular biology and an M.S. in biology from the University of California, San Diego. Her work has appeared in Scienceline, The Washington Post and Scientific American.

  • jeevdarshinik
    admin said:
    Doctors in New York will soon test whether blood from people who recover from COVID-19 can help treat the disease in others.

    Blood from recovered patients being tested as COVID-19 treatment : Read more
    how can their blood fight off covid-19
    all have antibodies whether they are a,b,ab or o and whether they are RH+VE OR RH-VE